CRISPR Therapeutics AG - Common Stock (CRSP)

CUSIP: H17182108

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
95,714,968
Total 13F shares
49,481,600
Share change
+8,335,986
Total reported value
$3,107,777,604
Put/Call ratio
99%
Price per share
$62.77
Number of holders
415
Value change
+$483,746,495
Number of buys
225
Number of sells
153

Quarterly Holders Quick Answers

What is CUSIP H17182108?
CUSIP H17182108 identifies CRSP - CRISPR Therapeutics AG - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CRISPR Therapeutics AG - Common Stock (CRSP) as of Q1 2022

As of 31 Mar 2022, CRISPR Therapeutics AG - Common Stock (CRSP) was held by 415 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,481,600 shares. The largest 10 holders included ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Capital International Investors, BlackRock Inc., LOOMIS SAYLES & CO L P, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, and ARMISTICE CAPITAL, LLC. This page lists 415 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.